Swipe om te navigeren naar een ander artikel
Immediate treatment of depression and anxiety may not always be necessary in resilient patients. This study aimed to determine remission rates of subthreshold depression and anxiety, incidence rates of major depressive and anxiety disorders, and predictors of these remission and incidence rates in visually impaired older adults after a three-month ‘watchful waiting’ period.
A pretest–posttest study in 265 visually impaired older adults (mean age 74 years), from outpatient low-vision rehabilitation services, with subthreshold depression and/or anxiety was performed as part of a randomised controlled trial on the cost-effectiveness of a stepped-care intervention. An ordinal logistic regression analysis was conducted. Main outcome measures were: (1) subthreshold depression and anxiety measured with the Centre for Epidemiologic Studies Depression Scale (CES-D) and the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A), and (2) depressive and anxiety disorders measured with the Mini International Neuropsychiatric Interview.
After a three-month watchful waiting period, depression and anxiety decreased significantly by 3.8 (CES-D) and 1.4 points (HADS-A) (p < 0.001). Of all participants, 34 % recovered from subthreshold depression and/or anxiety and 18 % developed a depressive and/or anxiety disorder. Female gender [odds ratio (OR) 0.49, 95 % confidence interval (CI) 0.28–0.86], more problems with adjustment to vision loss at baseline (OR 1.02, 95 % CI 1.00–1.03), more symptoms of depression and anxiety at baseline (OR 1.06, 95 % CI 1.02–1.10), and a history of major depressive, dysthymic, and/or panic disorder (OR 2.28, 95 % CI 1.28–4.07) were associated with lower odds of remitting from subthreshold depression and/or anxiety and higher odds of developing a disorder after watchful waiting.
Watchful waiting can be an appropriate step in managing depression and anxiety in visually impaired older adults. However, female gender, problems with adjustment to vision loss, higher depression and anxiety symptoms, and a history of a depressive or anxiety disorder confer a disadvantage. Screening tools may be used to identify patients with these characteristics, who may benefit more from higher intensity treatment or a shorter period of watchful waiting.
Davidson, J. R. J. (2010). Major depressive disorder treatment guidelines in America and Europe. Clinical Psychiatry, 71 Suppl E1.
NICE (2009). Depression in adults with a chronic physical health problem. Recourse document. National Institute for Health and Clinical Excellence (NICE). http://www.nice.org.uk/guidance/cg91/resources/guidance-depression-in-adults-with-a-chronic-physical-health-problem-pdf. Accessed 29 August 2014.
Cuijpers, P. (2009). Prevention: An achievable goal in personalized medicine. Dialogues in Clinical NeuroSciences,11(4), 447–454.
van Straten, A., Seekles, W., van ‘t Veer-Tazelaar, N., Beekman, A.T. & Cuijpers, P. (2010). Stepped care for depression in primary care: what should be offered and how? Medical Journal of Australia, 192(11 Suppl), S36–S39.
Dozeman, E., van Marwijk, H. W., van Schaik, D. J., Smit, F., Stek, M. L., van der Horst, H. E., et al. (2012). Contradictory effects for prevention of depression and anxiety in residents in homes for the elderly: A pragmatic randomized controlled trial. International Psychogeriatrics,24(8), 1242–1251. CrossRefPubMed
van’t Veer-Tazelaar, P. J., van Marwijk, H. W., van Oppen, P., van der Horst, H. E., Smit, F., Cuijpers, P., et al. (2011). Prevention of late-life anxiety and depression has sustained effects over 24 months: A pragmatic randomized trial. TheAmerical Journal of Geriatr Psychiatry, 19(3), 230–239.
van der Aa, H. P. A., Comijs, H. C., Penninx, B. W. J. H., van Rens, G. H. M. B., & van Nispen, R. M. A. (2015). Major depressive and anxiety disorders in visually impaired older adults. Investigative Ophthalmology & Visual Science,56(2), 849–854. CrossRef
Augustin, A., Sahel, J. A., Bandello, F., Dardennes, R., Maurel, F., Negrini, C., et al. (2007). Anxiety and depression prevalence rates in age-related macular degeneration. Investigative Ophthalmology & Visual Science,48(4), 1498–1503. CrossRef
Lotery, A., Xu, X., Zlatava, G., & Loftus, J. (2007). Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: Results from the UK cohort of a five-country cross-sectional study. British Journal of Ophthalmology,91(10), 1303–1307. PubMedCentralCrossRefPubMed
Tsai, S. Y., Cheng, C. Y., Hsu, W. M., Su, T. P., Liu, J. H., & Chou, P. (2003). Association between visual impairment and depression in the elderly. Journal of the Formosan Medical Association,102(2), 86–90. PubMed
Casten, R., & Rovner, B. (2008). Depression in age-related macular degeneration. Journal of Visual Impairment & Blindness,102(10), 591–599.
Adamson, J. A., Price, G. M., Breeze, E., Bulpitt, C. J., & Fletcher, A. E. (2005). Are older people dying of depression? Findings from the Medical Research Council trial of the assessment and management of older people in the community. Journal of the American Geriatrics Society,53, 1128–1132. CrossRefPubMed
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement,1(3), 385–401. CrossRef
Beekman, A. T., Deeg, D. J., van Limbeek, J., Braam, A. W., De Vries, M. Z., & van Tilburg, W. (1997). Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in The Netherlands. Psychological Medicine,27(1), 231–235. CrossRefPubMed
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry,59(Suppl 20), 22–33. PubMed
van Vliet, I. M., & de Beurs, E. (2007). The MINI-international neuropsychiatric interview. A brief structured diagnostic psychiatric interview for DSM-IV and ICD-10 psychiatric disoders. Tijdschrrift voor Psychiatrie,49(6), 393–397.
Horowitz, A., Reinhardt, J. P., Boerner, K., & Travis, L. A. (2003). The influence of health, social support quality and rehabilitation on depression among disabled elders. Aging & Mental Health,7(5), 342–350. CrossRef
Horowitz, A., Reinhardt, J. P., & Boerner, K. (2005). The effect of rehabilitation on depression among visually disabled older adults. Aging & Mental Health,9(6), 563–570. CrossRef
Horowitz, A., Reinhardt, J. P., & Raykov, T. (2007). Development and validation of a short-form adaptation of the Age-related Vision Loss scale: The AVL12. Jouranl of Visual Impairment Blindness,101(3), 146–159.
Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2009). An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics,50(6), 613–621. PubMed
Holloway, E. E., Sturrock, B. A., Lamoureux, E. L., Keeffe, J. E., & Rees, G. (2014). Depression screening among older adults attending low-vision rehabilitation and eye-care services: Characteristics of those who screen positive and client acceptability of screening. Australasian Journal on Ageing,. doi: 10.1111/ajag.12159. PubMed
- Watchful waiting for subthreshold depression and anxiety in visually impaired older adults
Hilde P. A. van der Aa
Esther Krijnen-de Bruin
Ger H. M. B. van Rens
Jos W. R. Twisk
Ruth M. A. van Nispen
- Springer International Publishing